Clinical Trial Update: Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for tumor lysate-pulsed dendritic cell immunotherapy in patients with glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• tumor lysate pulsed dendritic cell immunotherapy

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Glioblastoma | Phase 2 | Status: COMPLETED